A股收評:三大指數小幅收升,CPO概念、證券板塊等升幅居前
A股主要指數今日早盤震盪走弱,午後拉昇翻紅;截至收盤,滬指升0.12%報3032點,深證成指升0.5%,創業板指升0.76%。近2700股上升,全天成交8481億元,較昨日放量956億元。盤面上,機構預計全球光模塊市場2024年整體收入增長率將達到27%,CPO板塊全天強勢,中際旭創升超11%;高壓快充板塊走高,奧特迅升停;證券板塊午後拉昇,海通證券升超8%;電網設備、F5G概念及多元金融等板塊升幅居前。另外,機器人執行器板塊下挫,綠的諧波跌近10%;CRO板塊震盪走低,泰格醫藥一度下挫13%;船舶製造板塊走弱,中國重工領跌;航天航空、醫療服務及生物製品等板塊跌幅居前。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.